Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

NCT02182505 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

535

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Berodual® Respimat®, low dose
DRUG: Berodual® Respimat®, high dose
DRUG: Berodual® MDI

Sponsor

Boehringer Ingelheim